Molecular mechanism of ultraviolet-induced keratinocyte apoptosis

Journal of Interferon and Cytokine Research

Volumn 20, Issue 5, 2000, Pages 445-454

  Zhuang, Lihua ^a   Wang, Binghe ^a   Sauder, Daniel N ^a  

^a SUNNYBROOK RESEARCH INSTITUTE   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ADAPTOR PROTEIN; CASPASE; FAS LIGAND; PROTEIN BCL 2; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL CELL; APOPTOSIS; CYTOKINE PRODUCTION; KERATINOCYTE; MOLECULAR DYNAMICS; NONHUMAN; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROTEIN DOMAIN; REGULATORY MECHANISM; REVIEW; SIGNAL TRANSDUCTION; ULTRAVIOLET RADIATION;

ANIMALS; APOPTOSIS; CASPASES; FAS LIGAND PROTEIN; HUMANS; KERATINOCYTES; MEMBRANE GLYCOPROTEINS; MICE; MODELS, BIOLOGICAL; SIGNAL TRANSDUCTION; TUMOR NECROSIS FACTOR-ALPHA; TUMOR SUPPRESSOR PROTEIN P53; ULTRAVIOLET RAYS;

ANIMALIA;

EID: 0034116817     PISSN: 10799907     EISSN: None     Source Type: Journal    
DOI: 10.1089/10799900050023852     Document Type: Review

References (100)

1. 1. KERR, J.F., WYLLIE, A.H., and CURRIE, A.R. (1972). Apoptosis: a basic biologic phenomenon with wide-ranging implications in tissue kinetic. Br. J. Cancer 26, 239-257.
2. 2. COHEN, J.J. (1993). Apoptosis. Immunol. Today 14, 126-130.
3. 3. JACOBSON, M.D., WEIL, M., and RAFF, M.C. (1997). Programmed cell death in animal development. Cell 88, 347-354.
4. 4. POLAKOWSKA, R.R., PIACENTINI, M., BARTLETT, R., GOLDSMITH, A., and HAAKE, A.R. (1994). Apoptosis in human skin development: morphogenesis, periderm and stem cells. Dev. Dyn. 199, 176-188.
5. 5. THOMPSON, C.B. (1995). Apoptosis in the pathogenesis and treatment of disease. Science 267, 1456-1462.
6. 6. CASCIOLA-ROSEN, L.A., ANHALT, G., and ROSEN, A. (1994). Autoantigens targeted in systemic lupus erythematosus are clustered in two populations of surface structures on apoptotic keratinocytes. J. Exp. Med. 179, 1317-1330.
7. 7. DEVARY, Y., ROSETTE, C., DIDONATO, J.A., and KARIN, M. (1993). NF-KB activation by ultraviolet light not dependent on a nuclear signal. Science 261, 1442-1445.
8. 8. SCHWARZ, A., BHARDWAJ, R., ARAGANE, Y., MAHNKE, K., RIEMANN, H., METZE, D., LUGER, T.A., and SCHWARZ, T. (1995). Ultraviolet-B-induced apoptosis of keratinocytes: evidenc for partial involvement of tumor necrosis factor-α in the formation of sunburn cells. J. Invest. Dermatol 104, 922-927.
9. 9. ZIEGLER, A., JONASON, A.S., LEFFELL, D.J., SIMON, J.A., SHARMA, H.W., KIMMELMAN, J., REMINGTON, L., JACKS, T., and BRASH, D.E. (1994). Sunburn and p53 in the onset of skin cancer. Nature 372, 773-776.
10. 10. KRIPE, M.I. (1993). In: Dermatology in General Medicine. T.B. Fitzpatrick, A.Z. Eisen, K. Wolff, I.M. Freedberg, and K.F. Austun, eds. New York: McGraw-Hill, pp. 797-804.
11. 11. ZHUANG, L., WANG., B., SHINDER, G.A., SHIVJI, G.M., MAK, T.W., and SAUNDER, D.N. (1999). TNF receptor p55 plays a pivotal role in murine keratinocyte apoptosis induced by ultraviolet B irradiation. J. Immunol. 162, 1440-1447.
12. 12. LEVERKUS, M., YAAR, M., and GILCHREST, B.A. (1997). Fas/Fas ligand interaction contributes to UV-induced apoptosis in human keratinocytes. Exp. Cell Res. 232, 255-262.
13. 13. ARAGANE, Y., KULMS, D., METZE, D., WILKES, G., POPPELMANN, B., LUGER, T.A., and SCHWARZ, T. (1998). Ultraviolet light induces apoptosis via direct activation of CD95 (Fas/APO-1) independently of its ligand CD95. J. Cell. Biol. 140, 171-182.
14. 14. CAMPBELL, C., QUINN, A.G., ANGUS, B., FARR, P.M., and REES, J.L. (1993). Wavelength specific patterns of p53 induction in human skin following exposure to UV radiation. Cancer Res. 53, 2697-2699.
15. 15. ENARI, M., HUG, H., and NAGATA, S. (1995). Involvement of an ICE-like protease in Fas-mediated apoptosis. Nature 375, 78-81.
16. 16. VASSALLI, P. (1992). The pathophysiology of tumor necrosis factors. Annu. Rev. Immunol. 10, 411-452.
17. 17. LEWIS, M., TARTAGLIA, L.A., LEE, A., BENNETT, G.L., RICE, G.C., WONG, G.H., CHEN, E.Y., and GOEDDEL, D.V. (1991). Cloning and expression of cDNAs for two distinct murine tumor necrosis receptors demonstrate one receptor is species specific. Proc. Natl. Acad. Sci. USA 88, 2830-2834.
18. 18. MILATOVICH, A., SONG, K., HELLER, R.A., and FRANCKE, U. (1991). Tumor necrosis factor receptor genes, TNFR1 and TNFR2, on human chromosomes 12 and 1. Somatic Cell Mol. Genet. 17, 519-523.
19. 19. GOODWIN, R.G., ANDERSON, D., JERZY, R., DAVIS, T., BRANNAN, C.I., COPELAND, N.G., JENKINS, N.A., and SMITH, C.A. (1991). Molecular coloning and expression of the type 1 and type 2 murine receptors for tumor necrosis factor. Mol. Cell. Biol. 11, 3020-3026.
20. 20. NAGATA, S., and GOLSTEIN, P. (1995). The Fas death factor. Science 267, 1449-1456.
21. 21. KISTON, J., RAVEN, T., JIANG, Y.-P., GOEDDEL, D.V., GILES, K.M., PUN, K.T., GRINHAM, C.J., BROWN, R., and FARROW, S.N. (1996). A death domain-containing receptor that mediates apoptosis. Nature 384, 372-375.
22. 22. BROJATSCH, J., NAUGHTON, J., ROLLS, M.M., ZINGLER, K., and YOUNG, J.A.T. (1996). CARI, a TNFR-related protein, is a cellular receptor for cytopathic avian leukosis-sarcom a viruses and mediates apoptosis. Cell 87, 845-855.
23. 23. ADOLF, R.A., GRELL, M., and SCHEURICH, P. (1993). Tumor necrosis factor. In: Epidermal Growth Factors and Cytokines. T.A. Luger and T. Schwarz, eds. New York: Marcel Dekker Inc., p 63.
24. 24. TARTAGLIA, L.A., WEBER, R.F., FIGARI, I.S., REYNOLDS, C., PALLADINO, M.A., JR., and GOEDDEL, D.V. (1991). The two different receptors for tumor necrosis factor mediate distinct cellular responses. Proc. Natl. Acad. Sci. USA 88, 9292-9296.
25. 25. WANG, B., FUJISAWA, H., ZHUANG, L., KONDO, S., SHIVJI, G.M., KIM, C.S., MAK, T.W., and SAUDER, D.N. (1997). Depressed Langerhans cell migration and reduced contact hypersensitivity response in mouse lacking TNF receptor p75. J. Immunol. 159, 6148-6155.
26. 26. HELLER, R.A., SONG, K., FAN, N., and CHANG, D.J. (1992). The p70 tumor necrosis factor receptor mediates cytotoxicity. Cell 70, 47-56.
27. 27. WEISS, T., GRELL, M., HESSABI, B., BOURTEELE, S., MULLER, G., SCHEUICH, P., and WAJANT, H. (1997). Enhancement of TNF receptor p60-mediated cytotoxicity by TNF receptor p80: requirement of the TNF receptor-associated factor-2 binding site. J. Immunol. 158, 2398-2404.
28. 28. BEG, A.A., and BALTIMORE, D. (1996). An essential role for NF-KB in preventing TNF-α induced cell death. Science 274, 782-784.
29. 29. TARTAGLIA, L.A., AYRES, T.M., WONG, G.H., and GOEDDEL, D.V. (1993). A novel domain within the 55kd TNF receptor signals cell death. Cell 74, 845-853.
30. 30. ZHENG, L., FISHER, G., MILLER, R.E., PESCHON, J., LYNCH, D.H., and LENARDO, M.J. (1995). Induction of apoptosis in mature T cells by tumor necrosis factor. Nature 377, 348-351.
31. 31. GRELL, M., DOUNI, E., WAJANT, H., LOHDEN, M., CLAUSS, M., mAXEINER, B., GEORGOPOULOS, S., LESSLAUER, W., KOLLIAS, G., PFIZENMAIER, K., and SCHEURICH, S. (1995). The transmembrane form of tumor necrosis factor is the prime activating ligand of the 80-kD tumor necrosis factor. Cell 83, 793-802.
32. 32. KOCK, A., SCHWARZ, T., KIRNBAUER, R., URBANSKI, A., PERRY, P., ANSEL, J.C., and LUGER, T.A. (1990). Human keratinocytes are a source for tumor necrosis factor α: evidence for synthesis and release upon stimulation with endotoxin or ultraviolet light. J. Exp. Med. 172, 1609-1614.
33. 33. SAUDER, D.N., and DYTOC, M.T. (1997). Cytokines. Curr. Prob. Dermatol. 9, 1-32.
34. 34. WANG, B., ZHUANG, L., FUJISAWA, H., SHINDER, G.A., FELICIANI, C., SHIVJI, G.M., SUZUKI, H., AMERIO, P., TOTO, P., and SAUDER, D.N. (1999). Enhanced epidermal Langerhans cell migration in IL-10 knockout mice. J. Immunol. 162, 277-283.
35. 35. HSU, H., XIONG, J., and GOEDDEL, D.V. (1995). The TNF receptor 1-associated protein TRADD signals cell death and NF-KB activation. Cell 81, 495-504.
36. 36. SONG, H.Y., ROTHE, M., and GOEDDEL, D.V. (1996). The tumor necrosis factor-inducible zinc finger protein A20 interacts with TRAF1/TRAF2 and inhibits NF-KB activation. Proc. Natl. Acad. Sci. USA 93, 6721-6725.
37. 37. SHU, H.B., TAKEUCHI, M., and GOEDDEL, D.V. (1996). The tumor necrosis factor 2 signal transducers TRAF2 and c-IAP 1 are components of the tumor necrosis factor 1 signaling complex. Proc. Natl. Acad. Sci. USA 93, 13973-13978.
38. 38. STANKCOVSKI, I., and BALTIMORE, D. (1997). NF-KB activation: the 1 KB kinase revealed? Cell 91, 299-302.
39. 39. VAN ANTWERP, D.J., MARTIN, S.J., KAFRI, T., GREEN, D.R., and VERMA, I.M. (1996). Suppression of TNF-α-induced apoptosis by NF-KB. Science 274, 787-789.
40. 40. YEH, W.C., SHAHINIAN, A., SPEISER, D., KRAUNUS, J., BILLIA, F., WAKEHAM, A., DE LA POMPA, J.L., FERRICK, D., HUM, B., ISCOVE, N., OHASHI, P., ROTHE, M., GOEDDEL, D.V., and MAK, T.W. (1997). Early lethality, functional NF-kappaB activation, and increased sensitivity to TNF-induced cell death in TRAF2-deficient mice. Immunity 7, 715-725.
41. 41. WALLACH, D. (1997). Cell death induction by TNF: a matter of self control. Trends Biochem. Sci. 22, 107-109.
42. 42. KISCHKEL, F.C., HELLBARDT, S., BEHRMANN, I., GERMER, M., PAWLITA, M., KRAMMER, P.H., and PETER, M.E. (1995). Cytotoxicity-dependent APO-1 (Fas/CD95) associated proteins from a death-inducing signaling complex (DISC) with the receptor. EMBO J. 14, 5579-5588.
43. 43. VARFOLOMEEV, E.E., BOLDIN, M.P., GONCHAROV, T.M., and WALLACH, D. (1996). A potential mechanism of "cross-talk" between the p55 tumor necrosis factor receptor and Fas/APO-1: proteins binding to the death domains of the two receptors also bind to each other. J. Exp. Med. 183, 1271-1275.
44. 44. GRIFFITH, T.S., BRUNNER, T., FLETCHER, S.M., GREEN, D.R., and FERGUSON, T.A. (1995). Fas ligand-induced apoptosis as amechanism of immune privilege. Science 270, 1189-1192.
45. 45. OISHI, M., MAEDA, K., and SUGIYAMA, S. (1994). Distribution of apoptosis-mediating Fas antigen in human skin and effects of anti-Fas monoclonal antibody on human epidermal keratinocyte and squamous cell carcinoma lines. Arch. Dermatol. Res. 286, 396-407.
46. 46. SAYAMA, K., YONEHARA, S., WATANABE, Y., and MIKI, Y. (1994). Expression of Fas antigen on keratinocyte in vivo and induction of apoptosis in cultured keratinocytes. J. Invest. Dermatol. 103, 330-334.
47. 47. MATSUE, H., KOBAYASHI, H., HOSOKAWA, T., AKITAYA, T., and OHKAWARA, A. (1995). Keratinocytes constitutively express the Fas antigen that mediates apoptosis in IFNγ-treated cultured keratinocytes. Arch. Dermatol. Res. 287, 315-320.
48. 48. MARIANI, S.M., MATIBA, B., BAUMLER, C., and KRAMMER, P.H. (1995). Regulation of cell surface APO-1/Fas (CD95) ligand expression by metalloproteases. Eur. J. Immunol. 25, 2303-2307.
49. 49. HILL, L.L., OUHTIT, A., LOUGHLIN. S.M., KRIPKE, M.L., ANANTHASWAMY, H.N., and OWEN-SCHAUB, L.B. (1999). Fas ligand: a sensor for DNA damage critical in skin cancer etiology. Science 285, 898-900.
50. 50. GUTIERREZ-STELL, C., WRONE-SMITH, T., SUN, X., KRUEGER, J.G., COVEN, T., and NICKOLOFF, B.J. (1998). Sunlight-induced basal cell carcinoma tumor cells and ultraviolet B-irradiated psoriatic plaques express Fas ligand (CD95L). J. Clin. Invest. 101, 33-39.
51. 51. HILL, L.L., SHREEDHAR, V.K., KRIPKE, M.L., and OWENS-CHAUB, L.B. (1999). A critical role for Fas ligand in the active suppression of systemic immune responses by ultraviolet radiation. J. Exp. Med. 189, 1285-1293.
52. 52. FISHER, M.S., and KROPKE, M.I. (1982). Suppressor T lymphocytes control the development of primary skin cancers in ultraviolet-irradiated mice. Science 216, 1133-1134.
53. 53. OWEN-SCHAUB, L.B., VAN GOLEN, K.L., HILL, L.L., and PRICE, J.E. (1998). Fas and Fas ligand interactions suppress melanoma lung metastasis. J. Exp. Med. 188, 1717-1723.
54. 54. WANG, C.U., MAYO, M.W., and BALDWIN, A.S. (1996). TNF-cancer therapy-induced apoptosis: protection by inhibition of NF-KB. Science 274, 784-787.
55. 55. KASIBHATLA, S., BRUNNER, T., GENESTIER, L., ECHEVERRI, F., MAHBOUBI, A., and GREEN, D.R. (1998). DNA damaging agents induce expression of Fas ligand and subsequent apoptosis in T lymphocytes via the activation of NF-KB and Ap-1. Mol. Cell 1, 543-551.
56. 56. LANE, D.P. (1992). p53, guardian of the genome. Nature 358, 15-16.
57. 57. GREENBLATT, M.S., BENNETT, W.P., HOLLSTEIN, M., and HARRIS, C.C. (1994). Mutations in the p53 tumor suppressor gene: clues to cancer etiology and molecular pathogenesis. Cancer Res. 54, 4855-4878.
58. 58. BRASH, D.E., ZIEGLER, A., JONASON, A.S., SIMON, J.A., KUNALA, S., and LEFFELL, D.J. (1996). Sunlight and sunburn in human skin cancer: p53, apoptosis, and tumor promotion. J. Invest. Dermatol. Symp. Proc. 1, 136-142.
59. 1 arrest and apoptosis. Cancer Res. 54, 1169-1174.
60. 60. REED, M.B., WOELKER, P., WANG, Y., WANG, M., ANDERSON, E., and TEGTMEYER, P. (1995). The C-terminal domain of p53 recognizes DNA damaged by ionizing rediation. Proc. Natl. Acad. Sci. USA 92, 9455-9459.
61. 61. KRAEMER, K.H., LEE, M.M., ANDREW, A.D., and LAMBERT, W.C. (1994). The role of sunlight and DNA repair in melanoma and nonmelanoma skin cancer. The xeroderma pigmentosum paradigm. Arch. Dermatol. 130, 1018-1021.
62. 62. LI, G., HO, V.C., MITCHELL, D.L., TROTTER, M.J., and TRON, V.A. (1997). Differentiation-dependent p53 regulation of nucleotide excision repair in keratinocytes. Am. J. Pathol. 150, 1457-1464.
63. 63. LI, G., HO, V.C., BEREAN, K., and TRON, V.A. (1995). Ultraviolet radiation induction of squamous cell carcinomas in p53 transgenic mice. Cancer Res. 55, 2070-2074.
64. 64. BRASH, D.E., RUDOLPH, J.A., SIMON, J.A., LIN, A., McKENNA, G.J., BADEN, H.P., HALPERIN, A.J., and POTEN, J. (1991). A role for sunlight in skin cancer: UV-induced p53 mutations in squamous cell carcinoma. Proc. Natl. Acad. Sci. USA 88, 10124-10128.
65. 65. MIYASHITA, T., KRAJEWSKI, S., KRAJEWSKA, M., WANG, H.G., LIN, H.K., LIEBERMANN, D.A., HOFFMAN, R., and REED, J.C. (1994). Tumor suppressor p53 is a regulator of Bcl-2 and Bax gene expression in vitro and in vivo. Oncogene 9, 1799-1805.
66. 66. BOISE, L.H., GONZALEZ-GARCIA, M., POSTEMA, C.E., DING, L., LINDSTEN, T., TURKA, L.A., MAO, X., NUNEZ, G., and THOMPSON, C. (1993). Bcl-x, a Bcl-2-related gene that functions as a dominant regulator of apoptotic death. Cell 74, 597-608.
67. 67. OLTVAI, Z.N., MILLMAN, C.L., and KORSMEYER, S.J. (1993). Bcl-1 heterodimerizes in vivo with a conserved homolog, Bax, that accelerates programmed cell death. Cell 74, 609-619.
68. 68. YANG, J., LIU, X., BHALLA, K., KIM, C.N., IBRADO, A.M., CAI, J., PENG, T.I., JONE, D.P., and WANG, X. (1997). Prevention of apoptosis by Bcl-2: release of cytochrome c from mitochondria blocked. Science 275, 1129-1132.
69. 69. LI, P., NIJHAWAN, D., BUDIHARDJO, I., SRINIVASULA, S.M., AHMAD, M., ALNEMRI, E.S., and WANG, X. (1997). Cytochrome c and dATP-dependent formation of Apaf-1/caspase-9 complex initiates an apoptotic protease cascade. Cell 91, 479-489.
70. 70. LEVINE, A.J. (1997). p53, the cellular gatekeeper for growth and division. Cell 88, 323-331.
71. 71. BENNETT, M., MACDONALD, K., CHAN, S.W., LUZIO, J.P., SIMARI, R., and WEISSBERG, P. (1998). Cell surface trafficking of Fas: a rapid mechanism of p53-mediated apoptosis. Science 282, 290-293.
72. 72. MULLER, M., WILDER, S., BANNASCH, D., ISRAELI, D., LEHIBACH, K., LI-WEBER, M., FRIEDMAN, S.L., GALLE, P.R., STREMMEL, W., OREN, M., and KRAMMER, P.H. (1998). p53 activates the CD95 (APO-1/Fas) gene in response to DNA damage by anticancer drugs. J. Exp. Med. 188, 2033-2045.
73. 73. GALLE, P.R., HOFMANN, W.J., WALCZAK, H., SCHALLER, H., OTTO, G., STREMMEL, W., KRAMMER, P.H., and RUNKEL, L. (1995). Involvement of the CD95 (APO-1/Fas) receptor and ligand in liver damage. J. Exp. Med. 182, 1223-1230.
74. 74. MULLER, A., STRAND, S., HUG, H., HEINEMANN, E.M., WALCZAK, H., HOFMANN, W.J., STREMMEL, W., KRAMMER, P.H. and GALLE, P.R. (1997). Drug-induced apoptosis in hepatoma cells is mediated by the CD95 99, 403-413.
75. 75. TRON, V.A., TROTTER, M.J., TANG, L., KRAJEWSKA, M., REED, J.C., HO, V.C., and LI, G. (1998). p53-regulated apoptosis is differentiation dependent in ultraviolet B irradiated mouse keratinocytes. Am. J. Pathol. 153, 579-585.
76. 76. BEROUD, C., VERDIER, F., and SOUSSI, T. (1996). p53 gene mutation: software and database. Nucleic Acids Res. 24, 147-150.
77. 77. JANASON, A.S., KUNALA, S., PRICE, G.J., RESTIFO, R.J., SPINELLI, H.M., PERSING, J.A., LEFELL, D., TARONE, R.E., and BRASH, D.E. (1996). Frequent clones of p53-mutated keratinocytes in normal human skin. Proc. Natl. Acad. Sci. USA 93, 14025-14029.
78. 78. LIGGETT, W.H., JR., and SIDRANSKY, D. (1998). Role of the p16 tumor suppressor gene in cancer. J. Clin. Oncol. 16, 1197-1206.
79. 79. ELLIS, R.E., YUAN, J.Y., and HORVITZ, H.R. (1991). Mechanisms and functions of cell death. Annu. Rev. Cell Biol. 7, 663-698.
80. 80. HENGARTNER, M.O., and HORVITZ, H.R. (1994). The ins and outs of programmed cell death during C. elegans development. Phil. Trans. R. Soc. 345, 243-246.
81. 81. YUAN, J., SHAHAM, S., LEDOUX, S., ELLIS, H.M., and HORVITZ, H.R. (1993). The C. elegans cell death gene ced-3 encodes a protein similar to mammalian interleukin-1β-converting enzyme. Cell 75, 641-652.
82. 82. WANG, S., MIURA, M., JUNG, Y.K., ZHU, H., LI, E., and YUAN, J. (1998). Murine caspase-11, an ICE-interacting protease, is essential for the activation of ICE. Cell 92, 501-509.
83. 83. HUMKE, E.W., NI. J., and DIXIT, V.M. (1998). ERICE, a novel FLICE-activatable caspase. J. Biol. Chem. 273, 15702-15707.
84. 84. AHMAD, M., SRINIVASULA, S.M., HEGDE, R., MUKATTASH, R., FERNANDES-ALNEMRI, T., and ALNEMRI, E.S. (1998). Identification and characterization of murine caspase-14, a new member of the caspase family. Cancer Res. 58, 5201-5205.
85. 85. ALNEMRI, E.S., LIVINGSTON, D.J., NICHOLSON, D.W., SALVESEN, G., THORNBERRY, N.A., WONG, W.W., and YUAN, J. (1996). Human ICE/CED-3 protease nomenclature. Cell 87, 171.
86. 86. ZAMZAMI, N., MARCHETTI, P., CASTEDO, M., DECAUDIN, D., MACHO, A., HIRSCH, T., SUSIN, S.A., POLIT, P.X., MIGNOTTE, B., and KROEMER, G. (1995). Sequential reduction of mitochondrial transmembrane potential and generation of reactive oxygen species in early programmed cell death. J. Exp. Med. 182, 367-377.
87. 87. KAUFMANN, S.H., DESNOYERS, S., OTTAVIANO, Y., DAVIDSON, N.E., and POIRIER, G.G. (1993). Specific proteolytic cleavage of poly (ADP-ribose) polymerase: an early marker of chemotherapy-induced apoptosis. Cancer Res. 53, 3976-3985.
88. 88. THORNBERRY, N.A., BULL, H.G., CALAYCAY, J.R., CHAPMAN, K.T., HOWARD, A.D., KOSTURA, M.J., MILLER, D.K., MOLINEAUX, S.M., WEIDNER, J.R., AUNINS, J., ELLISTON, K.O., AYALA, J.M., CASANO, F.J., CHIN, J., DING, G.J.F., EGGER, L.A., GAFFNEY, E.P., LIMJUCO, G., PALYHA, O.C., RAJU, S.M., ROLANDO, A.M., SALLEY, J.P., YAMIN, T.T., LEE, T.D., SHIVELY, J.E., MACCROSS, M., MUMFORD, R.A., SCHMIDT, J.A., and TOCCI, M.J. (1992). A novel heterodimeric cysteine protese is required for interleukin-1β processing in monocytes. Nature 356, 768-774.
89. 89. MIURA, M., ZHU, H., ROTTLLO, R., HARTWIEG, E.A., and YUAN, J. (1993). Induction of apoptosis in fibroblasts by IL-1β-converting enzyme, a mammalian homolog of the C. elegans cell death gene ced-3. Cell 75, 653-660.
90. 90. BOUDREAU, N., SYMPSON, C.J., WERB, Z., and BISSELL, M.J. (1995). Suppression of ICE and apoptosis in mammary epithelial cells by extracellular matrix. Science 267, 891-893.
91. 91. KOSTURA, M.J., TOCCI, M.J., LIMJUCO, G., CHIN, J., CAMERON, P., HILLMAN, A.G., CHARTRAIN, N.A., and SCHMIDT, J.A. (1989). Identification of a monocyte specific pre-interleukin 1β convertase activity. Proc. Natl. Acad. Sci. USA 86, 5227-5231.
92. 92. FRIEDLANDER, R.M., GAGLIARDINI, V., HARA, H., FINK, K.B., LI, W., MACDONALD, G., FISHMAN, M.C., GREENBERG, A.H., MOSKOWITZ, M.A., and YUAN, J. (1997). Expression of a dominant mutant of interleukin-1β converting enzyme in transgenic mice prevents neuronal cell death induced by trophic factor withdrawal and ischemic brain injury. J. Exp. Med. 185, 933-940.
93. 93. RAY, C.A., BLACK, R.A., KRONHEIM, S.R., GREENSTREET, T.A., SLEATH, P.R., SALVESEN, G.S., and PICKUP, D.J. (1992). Viral inhibition of inflammation: cowpox virus encodes an inhibitor of the interleukin-1β converting enzyme. Cell 69, 597-604.
94. 94. TEWARI, M., and DIXIT, V.M. (1995). Fas and tumor necrosis factor-induced apoptosis is inhibited by the poxvirus crmA gene product. J. Biol. Chem. 270, 3255-3260.
95. 95. GAGLIARDINI, V., FERNANDEZ, P.A., LEE, R.K., DREXLER, H.C., ROTELLO, R.J., FISHMAN, M.C., and YUAN, J. (1994). Prevention of vertebrate neuronal death by the crmA gene. Science 263, 826-828.
96. 96. DIMMELER, S., HAENDELER, J., NEHLS, M., and ZEIHER, A.M. (1997). Suppression of apoptosis by nitric oxide via inhibition of interleukin-1β-converting enzyme (ICE)-like and cysteine protease protein (CPP)-32-like proteases. J. Exp. Med. 185, 601-607.
97. 97. NICHOLSON, D.W., ALI, A., THORNBERRY, N.A., VAILLANCOURT, J.P., DING, C.K., GALLANT, M., GAREAU, Y., GRIFFIN, P.R., LABELLE, M., and LAZEBNIK, Y.A. (1995). Identification and inhibition of the ICE-CED-3 protease necessary for mammalian apoptosis. Nature 376, 37-43.
98. 98. JAESCHKE, H., FISHER, M.A., LAWSON, J.A., SIMMONS, C.A., FARHOOD, A., and JONES, D.A. (1998). Activation of caspase-3 (CPP32)-like proteases is essential for TNF-α-induced hepatic parenchymal cell apoptosis and neutrophil-mediated necrosis in a murine endotoxin shock model. J. Immunol. 160, 3480-3486.
99. 99. WOO, M., HAKEM, R., SOENGAS, M.S., DUNCAN, G.S., SHAHINIAN, A., KAGI, D., HAKEM, A., McCURRACH, M., KHOO, W., KAUFMAN, S.A., SENALDI, G., HOWARD, T., LOWE, S.W., and MAK, T.W. (1998). Essential contribution of caspase-3/CPP32 to apoptosis and its associated nuclear changes. Genes Dev. 12, 806-819.
100. 100. NEWTON, K., HARRIS, A.H., BATH, M.L., SMITH, K.G.C., and ATRASSER, A. (1998). A dominant interfering mutant of FADD/MORT1 enhances deletion of autoreactive thymocytes and inhibits proliferation of mature T lymphocytes. EMBO J. 18, 706-718.